EORTC-55954-GCG

A randomized phase III study of chemotherapy and radiotherapy versus radiotherapy alone as adjuvant treatment to patients with node positive stages Ib or IIa cervix cancer (EO ORTC/NSGO/COSA/MRC intergroup trial)
Trial StatusAll trial activities ended
DatesDate of activation: 15-Dec-97
Closed on : 22-Dec-99
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size700
Number of steps1
Drug
Study Staff
Type of cancerCervical
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Clinical Oncology Society of Australia
Medical Research Council Clinical Trial Unit
Nordic Society of Gynecological Oncology
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00003209
EudraCT
@
Back to Protocol section